Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects

CD34+ circulating progenitor cells (CD34+CPCs) are a population of multipotent cells which can delay the development of atherosclerosis and cardiovascular disease (CVD) in conditions of increased CV risk. MicroRNAs (miRs) 221 and 222 modulate different genes regulating angiogenesis and inflammation;...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandraffino, Giuseppe, Aragona, Caterina Oriana, Cairo, Valentina, Scuruchi, Michele, Lo Gullo, Alberto, D’Ascola, Angela, Alibrandi, Angela, Loddo, Saverio, Quartuccio, Sebastiano, Morace, Carmela, Mormina, Enricomaria, Basile, Giorgio, Saitta, Antonino, Imbalzano, Egidio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354372/
https://www.ncbi.nlm.nih.gov/pubmed/28301500
http://dx.doi.org/10.1371/journal.pone.0173030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354372/
https://www.ncbi.nlm.nih.gov/pubmed/28301500
http://dx.doi.org/10.1371/journal.pone.0173030

Ejemplares similares